Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Kemizob - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Kemizob

Approved

STANDARD

Kemizob

Venus Remedies Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 3bda79cc0d734ca0
Company: Venus Remedies Limited
Type: Standard

Approval Details

Approval Id: 3bda79cc0d734ca0
Drug Approval Philippines Name: Kemizob
Product Name: Kemizob
Registration Number: DRP-9173
Brand Name: Kemizob
Generic Name: Bortezomib
Dosage Form: Lyophilized Powder For Solution For Injection (I.V./S.C.)
Dosage Strength: 3.5 mg
Manufacturer: Venus Remedies Limited
Importer: Aglobal Care, inc.
Distributor: Aglobal Care, inc.
Company Detail Path: /organization/venus-remedies-limited
Issuance Date: 25 September 2020
Expiry Date: 25 September 2025
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

3bda79cc0d734ca0

Type

Standard

Back to Philippines FDA Approvals